Gynecological cancers, including ovarian, cervical, uterine, and endometrial cancers, remain some of the most complex malignancies to study. While survival has improved in many cancers, uterine corpus cancer is trending upward; in 2025, the U.S. is expected to see 69,120 new cases and 13,860 deaths, and mortality increased about 1.5% per year from 2013 to 2022. These trends point to the need for deeper molecular data to guide translational research.

Gynecological cancers, including ovarian, cervical, uterine, and endometrial cancers, remain some of the most complex malignancies to study. While survival has improved in many cancers, uterine corpus cancer is trending upward; in 2025, the U.S. is expected to see 69,120 new cases and 13,860 deaths, and mortality increased about 1.5% per year from 2013 to 2022. These trends point to the need for deeper molecular data to guide translational research.

The spatial transcriptomics field provides unrivaled insights into gene expression within intact tissue architecture which is crucial for both exploratory discovery and targeted hypothesis testing. Two paradigms stand out: the 10x Genomics Visium HD platform and Xenium Prime (e.g., Xenium Prime 5K imaging-based assay). This post dissects their core technologies, strengths, and optimal use cases for advanced genomic research.

Signios Biosciences details how advanced single-cell and spatial transcriptomics support neuroscience research into Alzheimer’s, FTD, TBI, and Friedreich’s Ataxia, aiding new therapy development.

Signios Biosciences details how advanced single-cell and spatial transcriptomics support neuroscience research into Alzheimer’s, FTD, TBI, and Friedreich’s Ataxia, aiding new therapy development.

Today, we launch Signios Bio, a rebrand of what was previously known as MedGenome US Research Services. With a focus on scientific collaboration and breakthrough discovery, Signios Bio offers an integrated end-to-end suite of multiomic technologies.

Traumatic brain injury (TBI) poses complex challenges for researchers aiming to understand cellular responses post-injury. Professor Michelle H. Theus of Virginia Tech partnered with MedGenome to shed light on the cellular dynamics underlying injury progression and recovery on a murine TBI model using single-cell and spatial transcriptomics.

The immune system is a complex network of cells and molecules that defend the body against foreign invaders. Central to this defense mechanism are the T and B cells, which play a critical role in adaptive immunity.

The Human Cell Atlas (HCA) consortium has unveiled a landmark collection of over 40 studies from more than 100 countries, marking a significant leap in our understanding of the human body. Published across Nature and its affiliated journals, this updated release represents years of collaborative effort, utilizing cutting-edge single-cell and spatial transcriptomics technologies to map the cellular composition of tissues in unprecedented detail. These findings pave the way for breakthroughs in regenerative medicine, diagnostics, and the treatment of complex diseases.

Lung cancer remains the leading cause of cancer-related deaths globally, accounting for 18.4% of all cancer fatalities. Smoking is the primary cause of lung cancer, responsible for 80-90% of lung cancer deaths, though other risk factors like secondhand smoke, radon, asbestos, and family history also play roles. Research efforts to improve early detection, such as low-dose CT scans and biomarker tests, offer promise, and machine learning tools are being developed to enhance CT scan accuracy.